Medicine & TechnologyNew research recently found that people who are considered to be in the upper portions of the 'healthy' body mass index or BMI range are at higher risk of contracting severe COVID-19.
Since COVID-19 started its worldwide transmission, cases of influenza viruses reported to the World Health Organization have plummeted to minuscule levels.
New research recently found populations with shift work or those working on irregular hours are substantially more possible to become infected by COVID-19 than those who follow more traditional schedules at work.
Hawaii's Department of Health reported the first pediatric COVID-19 death of the state. It is a boy with underlying conditions who traveled with his vaccinated parents to Hawaii.
Pfizer's COVID-19 antiviral drug may be available by the end of this year. The drug may stop COVID-19 from reproducing in the patient's nose, throat, and lungs.
Media reports recently came out quoting a CSIR survey that has gone viral on social media after it claimed that smokers and vegetarians are less susceptible to COVID-19.
Japanese multinational technology company NEC Corporation announces collaboration between its African arm NEC XON, the United Nations Human Settlements Programme (UN-Habitat), and nonprofit organization Peace Winds Japan (PWJ), to provide a thermography camera in Kenya and help the nation in its fight against COVID-19.
A group of olfactory experts said that smell therapy could help treat COVID-19 smell loss. They also advise against using steroids that might not work.
A new study in human lung cells found a link between exposure to organophosphate pesticides and susceptibility to COVID-19, suggesting implications for veterans who were exposed to it during wartime.
Israel's Health Ministry recently said it is currently investigating a small number of occurrences of heart inflammation as a Pfizer COVID-19 vaccine side effect although it has not drawn any conclusions yet.
MIT researchers debunked policies by the World Health Organization and the US Centers for Disease Control and Prevention on social distancing, as such won't pose as much a threat for COVID-19 transmission as air currents indoors.
The CDC has recommended resumption of the use of the Johnson & Johnson COVID-19 vaccine in the United States after the stoppage of immunizations to investigate reports of rare blood clots.